Search

everythinglearnresearchcommunity

for

Search:↓

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

BST2 protein and certain T cells increase in early alopecia areata.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Medium-sized particles penetrate hair follicles better than smaller or larger ones, which could improve delivery of skin treatments.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Skin fat plays a key role in immune defense and healing beyond just storing energy.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Baricitinib successfully treated severe hair loss.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.